Susquehanna International Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Buy
12,400
+5,800
+88% +$276K ﹤0.01% 8849
2025
Q4
$247K Sell
6,600
-4,100
-38% -$167K ﹤0.01% 10406
2025
Q3
$433K Buy
+10,700
New +$353K ﹤0.01% 9292
2018
Q4
Sell
-7,400
Closed -$317K 9694
2018
Q3
$317K Buy
+7,400
New +$350K ﹤0.01% 7380

Other funds holding PAHC

Susquehanna International Group's PAHC Position: Q1 2026 in Review

Susquehanna International Group increased its Phibro Animal Health (PAHC) stake by 17% in Q1 2026, buying an estimated $47K and bringing the position to 6,698 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10400.

Susquehanna International Group first reported a position in PAHC in Q2 2014 and has held it in 22 quarters since. The position peaked at $1.9M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Susquehanna International Group held 6,698 shares of Phibro Animal Health worth $370K as of Q1 2026.
  • Susquehanna International Group bought 987 Phibro Animal Health shares in Q1 2026, an estimated $47K.
  • Phibro Animal Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10400 holding.
  • Susquehanna International Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 22 quarters since.
  • Susquehanna International Group's Phibro Animal Health position peaked at $1.9M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.